Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · Real-Time Price · USD

1.210

0.00 (0.00%)

At close: Jun 4, 2026, 4:00 PM EDT

1.190

-0.020 (-1.65%)

After-hours: Jun 4, 2026, 6:55 PM EDT

Sonoma Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	17.72	14.29	12.74	13.27	12.63	18.63
Revenue Growth (YoY)	26.83%	12.20%	-4.05%	5.10%	-32.21%	3.91%
Cost of Revenue	10.96	8.82	7.99	8.8	8.64	12.07
Gross Profit	6.76	5.47	4.75	4.48	3.99	6.56
Selling, General & Admin	7.39	7.36	7.58	8.84	9.76	9.45
Research & Development	2.14	1.81	1.87	0.21	0.13	0.56
Total Operating Expenses	9.53	9.18	9.45	9.05	9.88	10.01
Operating Income	-2.77	-3.71	-4.7	-4.57	-5.89	-3.45
Other Non-Operating Income (Expense)	-0.68	0.8	-0.33	-0.61	0.47	-0.45
Total Non-Operating Income (Expense)	-0.68	0.8	-0.33	-0.61	0.47	-0.45
Pretax Income	-3.45	-2.91	-5.03	-5.18	-5.42	-3.9
Provision for Income Taxes	0.08	-0.55	0.2	0.03	0.33	-0.71
Net Income	-3.37	-3.46	-4.84	-5.15	-5.09	-3.95
Earnings From Discontinued Operations	-	-	-	-	-	0.67
Net Income to Common	-3.37	-3.46	-4.84	-5.15	-5.09	-3.95
Shares Outstanding (Basic)	2	1	0	0	0	0
Shares Outstanding (Diluted)	2	1	0	0	0	0
Shares Change (YoY)	60.67%	172.75%	168.12%	27.93%	32.92%	35.14%
EPS (Basic)	-1.95	-2.79	-10.63	-30.40	-38.40	-39.40
EPS (Diluted)	-1.95	-2.79	-10.63	-30.40	-38.40	-39.40
Shares Outstanding	1.73	1.63	0.78	0.25	0.16	0.1
Free Cash Flow	-3.72	-0.17	-2.4	-6.42	-4.39	-3.56
Free Cash Flow Per Share	-2.25	-0.14	-5.27	-37.84	-33.06	-35.64
Gross Margin	38.16%	38.25%	37.26%	33.73%	31.62%	35.21%
Operating Margin	-15.61%	-25.97%	-36.91%	-34.43%	-46.62%	-18.51%
Profit Margin	-19.92%	-16.50%	-41.04%	-39.31%	-45.53%	-24.77%
FCF Margin	-20.99%	-1.18%	-18.85%	-48.38%	-34.72%	-19.09%
EBITDA	-2.63	-3.57	-4.53	-4.45	-5.7	-3.22
EBITDA Margin	-14.83%	-25.00%	-35.53%	-33.49%	-45.15%	-17.30%
EBIT	-2.77	-3.71	-4.7	-4.57	-5.89	-3.45
EBIT Margin	-15.61%	-25.97%	-36.91%	-34.43%	-46.62%	-18.51%
Effective Tax Rate	-2.32%	18.92%	-3.90%	-0.64%	-6.13%	18.27%

SEC Filings: 10-K · 10-Q